|Bid||24.69 x 1100|
|Ask||64.50 x 800|
|Day's range||60.38 - 62.24|
|52-week range||55.16 - 76.70|
|Beta (5Y monthly)||1.10|
|PE ratio (TTM)||33.76|
|Earnings date||26 July 2022 - 01 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||72.57|
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Hilco Redevelopment Partners (HRP) announced that Integra LifeSciences, NASDAQ: IART (https://www.integralife.com/home), a leading global medical technology company, will occupy approximately 100,000 square feet of HRP's newly redeveloped state-of-the-art life science space at 400 Wood Road in Braintree, MA. The new space will manufacture surgical reconstruction devices used in the treatment of areas such as hernia repair and breast reconstruction.
Integra's (IART) updated 2022 financial guidance calls for strong year-over-year organic growth.